Peptide Pharmacology
Referenced profiles of 27 peptides. Status reflects the US FDA as of November 2026.
Incretin and amylin pathways, appetite and glucose control.
GHRH analogues and GH secretagogues.
Peptides studied for tendon, gut and wound healing.
Copper peptides, melanocortin agonists and blends.
Central melanocortin pathways.
Neuropeptides and mitochondrial-derived peptides.
| Peptide | Class | US status | Profile |
|---|---|---|---|
| 5-Amino-1MQ | NNMT inhibitor (small molecule) | Not FDA-approved | View → |
| Afamelanotide (Melanotan I) | Melanocortin agonist | FDA-approved | View → |
| BPC-157 | Gastric peptide fragment | Not FDA-approved | View → |
| BPC-157 / TB4 blend | Blend | Not FDA-approved | View → |
| Cagrilintide | Amylin analogue | Investigational | View → |
| CJC-1295 | GHRH analogue | Not FDA-approved | View → |
| CJC-1295 / Ipamorelin blend | Blend | Not FDA-approved | View → |
| DSIP | Neuropeptide | Not FDA-approved | View → |
| Epithalon | Synthetic tetrapeptide | Not FDA-approved | View → |
| GHK-Cu | Copper tripeptide | Not FDA-approved | View → |
| GLOW blend | Blend | Not FDA-approved | View → |
| Ipamorelin | Ghrelin receptor agonist | Not FDA-approved | View → |
| KLOW blend | Blend | Not FDA-approved | View → |
| KPV | α-MSH-derived tripeptide | Not FDA-approved | View → |
| Melanotan II | Melanocortin agonist | Not FDA-approved | View → |
| MOTS-c | Mitochondrial-derived peptide | Not FDA-approved | View → |
| N-Acetyl Semax Amidate | ACTH(4-10) analogue | Not FDA-approved | View → |
| NAD⁺ (buffered) | Coenzyme (not a peptide) | Not FDA-approved | View → |
| PT-141 (bremelanotide) | Melanocortin agonist | FDA-approved | View → |
| Retatrutide | GIP / GLP-1 / glucagon agonist | Investigational | View → |
| Semaglutide | GLP-1 receptor agonist | FDA-approved | View → |
| Sermorelin | GHRH analogue | Formerly approved | View → |
| TB-500 | Thymosin β4 fragment | Not FDA-approved | View → |
| Tesamorelin | GHRH analogue | FDA-approved | View → |
| Tesamorelin / Ipamorelin blend | Blend | Not FDA-approved | View → |
| Thymosin β4 (TB4) | Thymosin | Not FDA-approved | View → |
| Tirzepatide | GIP / GLP-1 receptor agonist | FDA-approved | View → |